Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
B2151 STF-62247Target: AutophagySummary: Autophagy inducer in renal cell
-
B6032 CB-5083Target: p97Summary: p97 inhibitor
-
A4443 Gliotoxin1 CitationTarget: 20S proteasomal chymotrypsin|Geranylgeranyltransferase I|FarnesyltransferaseSummary: 20S proteasome inhibitor
-
A4429 Vialinin ATarget: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2Summary: USP/isopeptidase T (IsoT)/UCH-L1 DUB inhibitor
-
A8629 DBeQTarget: P97 ATPaseSummary: P97 ATPase inhibitor
-
A8813 NSC697923Target: Ub-conjugating enzyme (E2) complexSummary: Inhibitor of E2 complex Ubc13-Uev1A,cell permeable and selective
-
A8179 MG-2621 CitationTarget: ProteasomeSummary: Proteasome inhibitor
-
A4083 Rocilinostat (ACY-1215)1 CitationTarget: Histone Deacetylases (HDACs)Summary: Selective HDAC6 inhibitor
-
A2606 Epoxomicin25 CitationSummary: Proteasome inhibitor
-
A2585 MG-13226 CitationTarget: ProteasomeSummary: Proteasome inhibitor, Cell permeable, reversible